CD3-BINDENDE POLYPEPTIDE
European patent · EP3352760 · In force
Register entry
- Publication number
- EP3352760
- Application number
- EP16849533
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 21, 2016
- Published
- Aug 1, 2018
- Granted
- Mar 11, 2026
- Protection ends at the latest
- Sep 20, 2036
- Next annual fee due
- Sep 30, 2027
- IPC classes
- C07K 16/28 (2006.01)A61K 39/395 (2006.01)C07K 16/30 (2006.01)C07K 16/40 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201562221190 P 21.09.2015
- PCT application
- PCT/US2016/052942 21.09.2016
- PCT publication
- WO2017/053469 30.03.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Jun 15, 2026
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 15.06.2026
- Mar 11, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 11.03.2026
Parties
Holder
Inventor
TAN, Philip
Seattle, Washington 98121, US
BLANKENSHIP, John W.
Seattle, Washington 98121, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.